Format

Send to

Choose Destination
Arthritis Rheum. 2011 Apr;63(4):867-70. doi: 10.1002/art.30207.

Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?

PMID:
21452309
DOI:
10.1002/art.30207
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center